Abstract
Introduction:COVID-19 pandemic has multiple ocular manifestations. We report 2 cases of central serous chorioretinopathy, following COVID19 infection. Case Presentation: We diagnosed two middle aged patients with central serous chorioretinopathy one week post COVID-19 infection. Both patients were admitted in COVID-19 ward. Case 1 was a male diabetic and required ventilator assisted respiration. Case 2 was a female patient with no systemic diseases. Both patients were given intravenous (IV) methylprednisolone for 2 weeks followed by oral prednisolone. Case 1developed CSCR in right eye while the other patient developed CSCR in both eyes. Conclusion: The possibility of developing CSCR should be kept in mind by the treating physician in Covid 19 patients treated with steroids. Early involvement of ophthalmologist can lead to timely and effective management of same
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
